As summarized in Table 2, Chi-square test showed that the levels of PLOD2 protein significantly correlated with the status of pathology classification (WHO I–II vs. III–IV) in 125 glioma patients (P = 0.011). The gene discussed is PLOD2; the disease is central nervous system cancer.